Rosie Forster, Queen Elizabeth Hospital Birmingham, with the CALEX and Roche cobas c702
Introducing in-house Calprotectin Testing Directly on the Roche cobas® c702

Turbo Charged from the Start Rosie Forster and Karen Smith, Clinical Biochemistry, Queen Elizabeth Hospital Birmingham introduce Faecal Calprotectin testing into their laboratory using the BÜHLMANN fCAL® turbo assay. Faecal

Usability of a home-based test for the measurement of faecal calprotectin in IBD patients

In this video Caroline Bello from the University Hospital in Liege, Belgium presents the data of BÜHLMANN’s multicenter study with over 50 patients in Liege (Prof. Edouard Louis), Oslo (Dr.

Home vs. Hospital Based Analysis of Stool Calprotectin

Comparison of Two Diagnostic Methods for Monitoring Inflammatory Bowel Disease. In this video Anke Heida, a PhD student from the IBD Centre, Groningen University Medical Center, Netherlands presents her poster at

Using Faecal Calprotectin Testing in Primary Care

Dr James Turvill, York Teaching Hospital NHS Foundation Trust discusses the York Faecal Calprotectin Care Pathway. Using Faecal Calprotectin Testing in Primary Care: Watch the Video. Calprotectin Testing in Primary

Anita-Grunauer evaluates fCAL turbo on Roche c501
City Hospital Triemli Optimizes Laboratory Workflow For Calprotectin Testing

Interview with Anita Grünauer (BMA), Dr. Jasmin Barman-Aksözen (Head of Department Chemistry), and Predrag Nesic (Head of Department BMA Chemistry), Institute for Laboratory Medicine, City Hospital Triemli, Zurich …the BÜHLMANN

Evaluating fCAL turbo - Beckman UniCel DxC 600
Children’s Hospital of Zurich introduces fCAL turbo on the Beckman UniCel DxC 600

Interview with Mara Barbieru Deputy Senior Biomedical Analyst, Department of Clinical Chemistry and Biochemistry, Children’s Hospital of Zurich “For years, we had wanted to run Calprotectin in-house and now finally we can offer this.”

BÜHLMANN fCAL turbo Evaluation
Bioanalytica Lucerne 2: BÜHLMANN fCAL® turbo evaluation on the Roche cobas® c501

Interview with Yvonne Schallberger, Bioanalytica Lucerne 2. BÜHLMANN fCAL turbo Evaluation “By introducing BÜHLMANN fCAL® turbo we can finally provide the service the gastroenterologists of the St. Anna Hospital longed

fCAL turbo faecal calprotectin assay
BÜHLMANN fCAL® turbo Faecal Calprotectin Assay Proves Consistent between Multiple Analysers

There has been much interest in the BÜHLMANN fCAL turbo faecal calprotectin assay since its UK launch in early 2016. With the increasing demand for faecal calprotectin tests there is a

Loading fCAL turbo faecal calprotectin tests onto the cobas 6000
On Board with fCAL® turbo at Cumberland Infirmary

Pamela Bowe, Team Manager in the Department of Biochemistry at the Cumberland Infirmary describes her experience in evolving laboratory procedures and introducing BÜHLMANN fCAL turbo to cope with the growing number of faecal calprotectin

Studying Calprotectin False at Luton and Dunstable University Hospital
False Positive Faecal Calprotectin?
The Camera Never Lies

Louise Asser, Specialist Biomedical Scientist at Luton and Dunstable University Hospital tells us about the work there, following up patients with a false positive calprotectin result. Using a pill-sized camera

IBDoc® – A Patient’s Perspective

Julia Edin, a Crohn’s patient from Norway tells us about her experience using IBDoc® at home.

Mercy_Hospital
Calprotectin Patient Self-Testing in Practice

NEW User Report: Monitoring calprotectin concentrations is important as an indicator of disease activity, the effectiveness of treatment and to predict relapses in Inflammatory Bowel Disease (IBD).